glp 1 and anesthesia guidelines Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus GLP-1 drugs and aspiration risk

Do you need more than simply hardware

[PubMed] [Google Scholar] 44

Hypoglycemia, nausea and weight gain can compromise the patients adherence to antidiabetic therapy over time

Effects on Obesity Obesity, as a chronic recurrent disease, is known to increase the risk of developing T2MD, hypertension, dyslipidemias, CVDs, NAFLD, and other diseases, leading to a poor quality of life and increased mortality (167)

17 Gallbladder disease, including gallstone formation known as cholelithiasis and inflammation of the gallbladder called cholecystitis, is a major problem, especially in people with obesity and T2DM, the population groups most frequently treated with GLP-1RAs

Cell 153:11941217 Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2